Effects of in Vivo Administration of Pentagastrin, Secretin, and 13-Nle-Motilin on the in Vitro Incorporation of14C-Leucine into Protein of Human Gastric Mucosa

Abstract
Under endoscopic control, biopsy specimens were taken from the oxyntic gland area of the stomach before and after administration of pentagastrin, synthetic secretin and 13-norleucine motilin (13-nle-motilin), respectively. In 29 volunteers, the basal rate of 14C-leucine incorporation into mucosal protein averaged 41.2 .+-. 7.7 .times. 103 cpm/mg protein (mean .+-. SD). One and 4 hours after s.c. administration of pentagastrin (6 .mu.g/kg body wt), values were significantly increased (P < 0.05) by 18.9 and 21.8%, respectively, with respect to the basal level. One hour after i.v. secretin, gastric mucosal protein synthesis was not substantially inhibited, whereas a 1 h continuous i.v. infusion of 13-nle-motilin (0.4 .mu.g/kg body wt per h) significantly decreased 14C-leucine incorporation rates by 17.5% (P < 0.05). In contrast to rats, 1 h after s.c. pentagastrin, protein synthesis in human duodenal mucosa was not altered. Pentagastrin has a trophic influence on gastric mucosa in man. The data are compatible with the hypothesis that gastrin and motilin may be involved in the regulation of human gastric mucosal protein synthesis.